CN102349990A - Traditional Chinese medicine for treating hepatitis B - Google Patents
Traditional Chinese medicine for treating hepatitis B Download PDFInfo
- Publication number
- CN102349990A CN102349990A CN2011103246512A CN201110324651A CN102349990A CN 102349990 A CN102349990 A CN 102349990A CN 2011103246512 A CN2011103246512 A CN 2011103246512A CN 201110324651 A CN201110324651 A CN 201110324651A CN 102349990 A CN102349990 A CN 102349990A
- Authority
- CN
- China
- Prior art keywords
- medicine
- hepatitis
- chinese medicine
- traditional chinese
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 24
- 239000002994 raw material Substances 0.000 claims description 9
- 210000003038 endothelium Anatomy 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 208000006454 hepatitis Diseases 0.000 abstract description 6
- 231100000283 hepatitis Toxicity 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 241000700605 Viruses Species 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 2
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 206010023126 Jaundice Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 5
- 230000003908 liver function Effects 0.000 description 5
- 239000009636 Huang Qi Substances 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 208000030208 low-grade fever Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 206010019668 Hepatic fibrosis Diseases 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102100034193 Aspartate aminotransferase, mitochondrial Human genes 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 101000799549 Homo sapiens Aspartate aminotransferase, mitochondrial Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 108090000279 Peptidyltransferases Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating hepatitis B, which is prepared from nearly 20 kinds of traditional Chinese medicines such as radix bupleuri, giant knotweed rhizome, rheum officinale and the like. The medicine disclosed by the invention has the beneficial effects of more comprehensive treatment function and wide application range. The medicine is mainly used for improving the immunity of an organism and inhibiting and eliminating hepatitis virus; and meanwhile, by adopting more comprehensive liver protecting and caring measures, the medicine can be taken by patients with various ages, disease courses and physical signs. Proved by clinical application for tens of years, the traditional Chinese medicine has a definite curative effect and remarkable short-term and long-term effects.
Description
Technical field
The present invention relates to a kind of Chinese medicine of treating hepatitis B.
Background technology
The hepatitis B pathogenesis is complicated, and symptom is obstinate, and delay is difficult, thereby very harmful to human beings'health.Traditional medicine thinks that hepatitis B belongs to stagnation of liver-QI, hypochondriac pain, jaundice, pestilence, gathers category, its cause of disease be since positive QI-insufficiency unable get rid of evils in outside, cause the dark volt of epidemic disease poison and make state of an illness protracted course of disease.Its pathogenesis is that the heresy of epidemic disease caused by damp-heat pathogen poison is held back the volt taste, middle burnt stasis, and production of fire due to stagnation of damp, cloudy liquid in the consumer, and cause the hepatic and renal YIN deficiency; Its pathologic basis is liver,spleen,kidney three dirty imbalance of YIN and YANG, and pathogen is stopped up knot, the damp and hot tired choke blood stasis that stagnates.Traditional medicine is many for the Therapeutic Principle of hepatitis B to be main with the detoxifcation regulating qi to disperse stagnation, combines the state of an illness to develop and carries out determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, and combine the human body immunity improving function to suppress viral; Improve the liver blood circulation; Anti-hepatic fibrosis promotes hepatocyte to repair, and its Therapeutic Method is with nourishing the liver, easing the affected liver, soothing liver-QI; Regulating the flow of QI to dissipate blood stasis is set upright, the clearing away heat-damp and promoting diuresis detoxifcation.Though it is many to be used to treat the Chinese medicine of chronic viral hepatitis B at present; But; Because this disease is complicated and obstinate especially, existing levels of drugs also has very big gap with effective the healing, also needs constantly to innovate in practice for traditional therapy; This just requires us further to make more effort and innovation, and what the present invention was exactly in this respect to be done once actively attempts.
Summary of the invention
The technical problem that the present invention will solve is to provide a kind of Chinese medicine of treating hepatitis B, this medicine have the scope of application extensively, the advantage of determined curative effect.
Raw material composition and weight portion proportioning that the present invention treats the Chinese medicine basis side of hepatitis B are:
Can also add in the above-mentioned basis side: Herba Epimedii 10-30 part, Radix Pseudostellariae 5-15 part.
Can also add in the above-mentioned basis side: Fructus Ligustri Lucidi 5-20 part, Herba Ecliptae 5-15 part,
Or add: Radix Salviae Miltiorrhizae 5-15 part, Endothelium Corneum Gigeriae Galli 5-15 part, Rhizoma Cyperi 10-15 part.
Below be the basic property of medicine of various components in the medicine of the present invention
Radix Bupleuri: evacuate and bring down a fever the yang invigorating soothing liver-QI.
Rhizoma Polygoni Cuspidati: the detoxifcation of dispeling the wind, anti-inflammatory analgetic, remuval of damp and hot jaundice.
Radix Et Rhizoma Rhei: attack stagnant, clearing away damp-heat, pathogenic fire purging, removing heat from blood, blood stasis dispelling, detoxifcation.
Herba Taraxaci: diuresis, cathartic, jaundice eliminating subcutaneous ulcer, function of gallbladder promoting.
The Radix Astragali: invigorating QI to consolidate the body surface resistance, diuretic detumescent, expelling pus and toxin by strengthening QI, granulation promoting.
Herba Scutellariae Barbatae: heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, anticancer.
Rhizoma Smilacis Glabrae: detoxifcation, dehumidifying, sharp joint.
PINGDIMU: preventing phlegm from forming and stopping coughing, dampness removing, invigorate blood circulation.
Nidus Vespae: wind-expelling pain-stopping, counteracting toxic substances detumescence, killing parasites for relieving itching.
Folium Isatidis: heat clearing away, detoxifcation, removing heat from blood, hemostasis.
Radix Curcumae: regulating qi to disperse stagnation, heart fire-clearing upset-relieving, promoting the function of the gallbladder to alleviate jaundice.
Radix Glycyrrhizae: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, coordinating the actions of various ingredients in a prescription.
Fructus Lycii: nourishing the liver and kidney, replenishing vital essence to improve eyesight.
Hedyotidis Diffusae: heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, promoting urination to remove dampness.
Catharsii molossi: move back the stasis of blood, counteracting toxic substances, detumescence, relieving constipation.
Radix Sophorae Flavescentis: heat clearing and damp drying, parasite killing, diuresis.
Herba Artemisiae Scopariae: clearing away damp-heat, jaundice eliminating subcutaneous ulcer.
The Radix Paeoniae Alba: nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing are received antiperspirant.
Radix Paeoniae Rubra: clots absorbing, pain relieving, removing heat from blood, detumescence
Herba Epimedii: beneficial vital essence, benefit kidney-Yang.
Radix Pseudostellariae: mend strengthening spleen and lung, supplementing QI for promoting the production of body fluid.
Fructus Ligustri Lucidi: liver and kidney tonifying; Clearind deficient heat.
Herba Ecliptae: removing heat from blood, hemostasis, the kidney invigorating, tonifying YIN.
Radix Salviae Miltiorrhizae: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.
Endothelium Corneum Gigeriae Galli: promoting digestion and invigorating the stomach, arresting seminal emission.
Rhizoma Cyperi: the resolving depression of regulating the flow of vital energy, separate the breast side of body and stomach abdominal distention and pain.
Below be the composition principle of medicine of the present invention:
According to this disease of Traditional Chinese medical theory is that unable getting rid of evils gone out owing to positive QI-insufficiency, and the epidemic disease poison is dark to be lied prostrate and cause.Therefore inhibition virus and enhancing human body immunity power obviously are top-priority in the rule of treatment.The Radix Astragali in this prescription, Radix Glycyrrhizae, Hedyotidis Diffusae have warming and recuperating the spleen and kidney, effect that yang invigorating is supporing yang, help improving the immunity of body self.Rhizoma Polygoni Cuspidati, Fructus Lycii, Poria, the Radix Polygoni Multiflori, Herba Scutellariae Barbatae and Herba Hedyotidis Diffusae have QI invigorating, YIN nourishing and heat-clearing and toxic substances removing, antimicrobial and anti-inflammation efficacy, can just help inhibition and the removing of getting rid of evils, help antigen of hepatitis B virus.
In addition, the Herba Taraxaci in the prescription, Radix Scutellariae, the Radix Paeoniae Alba, Poria, Radix Sophorae Flavescentis, PINGDIMU are used for transaminase lowering.Herba Artemisiae Scopariae, Rhizoma Polygoni Cuspidati, Radix Paeoniae Rubra, Radix Et Rhizoma Rhei are used to fall hemobilirubin.Herba Artemisiae Scopariae, Radix Scutellariae, Radix Et Rhizoma Rhei, Radix Paeoniae Rubra, Radix Bupleuri, Radix Curcumae are used for promoting the function of the gallbladder to alleviate jaundice.The Radix Astragali, Radix Curcumae are used for anti-hepatic fibrosis; The Radix Polygoni Multiflori, the Radix Astragali, the Radix Paeoniae Alba are used to adjust Proteometabolism, and Radix Bupleuri, the Radix Polygoni Multiflori are used for AFL.Herba Artemisiae Scopariae and Radix Polygoni Multiflori can reduce serum cholesterol, and Herba Artemisiae Scopariae can promote bile secretion, and antibacterial diuresis has defencive function to liver.
Also selected Nidus Vespae, these two kinds of medicines of Catharsii molossi among the we for use, these two kinds of medicines have been received tangible special-effect in treatment is used.
The preparation of medicine of the present invention and instructions of taking are to choose medicine material in the prescription ratio, through cleaning, after the drying, are crushed to 60 orders, and morning every day, evening are respectively obeyed 5 grams, and three months is a course of treatment.Said medicine can also be processed pill, decoction or incapsulate and take.
The beneficial effect of medicine of the present invention is: this medicine has the comprehensive treatment function and the scope of application widely.This medicine from human body immunity improving power with suppress to remove hepatitis virus and start with, also adopted comparatively comprehensively simultaneously protect the liver, the hepatoprotective measure, all can take for the patient of various ages, the course of disease, sign.Its determined curative effect of clinical practice proof of many decades, short-term and long-term effect are all very significantly.
The specific embodiment
Example 1
Raw material composition and weight portion proportioning that the present invention treats the Chinese medicine basis side of hepatitis B are:
Example 2
Below be the concrete raw material and the weight portion proportioning of medicine of the present invention:
Example 3
Below be the concrete raw material and the weight portion proportioning of medicine of the present invention:
Example 4
Below be the concrete raw material and the weight portion proportioning of medicine of the present invention:
Example 5
The efficacy analysis of medicine of the present invention:
1, in XX, the man, 39 years old, in April, 2008 hepatitis B two double check result great three positives; Liver function test result: glutamate pyruvate transaminase 118, GOT2 23; Take the prescription treatment of the embodiment of the invention 1 to this clinic treatment in June, 2008, and liver function energy valley third, glutamic oxaloacetic transaminase, GOT all drop to normal value after three weeks.Take medicine altogether 3 courses of treatment, on November 25 the same year, chemical examination " five indexes of hepatitis b " is all negative.
2, Liu so-and-so, the man, 23 years old, hepatitis B great three positive, abnormal liver function, glutamate pyruvate transaminase 85, glutamate-oxaloacetate transaminase 06, transpeptidase 134 were found in May, 2008 health check-up.Begin to take the prescription treatment of the embodiment of the invention 1 in June, 2008, second positive antibody of check mid-October in the same year chemical examination five indexes of hepatitis b, all the other each item total negatives.
3, the king so-and-so, the man, 33 years old, found the hepatitis B great three positive in March, 2005, abnormal liver function has and detests light symptoms such as greasy, low grade fever.Bring into use the prescription of the embodiment of the invention 2 May in the same year.In JIUYUE, 2006 check chemical examination, five indexes of hepatitis b is all negative.
4, Liu XX, man, 43 years old, demobilized soldier.Had a liver complaint 7 years, in May, 2002 five indexes of hepatitis b result of laboratory test great three positive.Have tooth root to bleed, low grade fever is weak, be sick of greasy, persistence symptom such as become thin.Went to a doctor this month, begins to obey the prescription treatment of the embodiment of the invention 2, and one and a half months left and right sides hepatopathy symptom disappears basically, diet and weight increase.Laboratory examination in mid-March, 2003, liver function is normal, and hepatitis B two double each items are negative.
5, king XX, woman, 47 years old.Have a liver complaint more than 4 years, laboratory examination in by the end of June, 2003 is the hepatitis B great three positive, and menoxenia is arranged, and discontinuity low grade fever is weak, detests greasyly, and the hepatic region weighs down symptoms such as painful.Begin to take the prescription treatment of the embodiment of the invention 3 at the beginning of 7 months, in mid-May, 2004 chemical examination, hepatitis B surface antibody forms, and all the other each items are negative.The complete obiteration of hepatopathy symptom.
6, king XX, the man, 55 years old, hepatitis B small three positive 11 years, hepatic region had twinge to weigh down the sense of expanding, pale complexion, sexual hypofunction.In Decembers, 2002 are taken the prescription of the embodiment of the invention 3, check in May next year, and the antigen total negative, and immune antibody appears, original transference cure.
Example surplus the Drug therapy hepatitis B 200 of the present invention, the treatment back hepatitis B antigen person of turning out cloudy 52 people, great three positive 29 people wherein, small three positive 23 people.Transfer to normal behind the unusual patient treatment of 92% liver function index.Employed medicine embodiment 1 side of above-mentioned healing patient is 22 examples, and embodiment 2 sides are 11 examples, and embodiment 3 sides are that 10 routine embodiment 4 sides are 9 examples.
Claims (4)
1. Chinese medicine of treating hepatitis B is characterized in that: the raw material of this medicine is formed and the weight portion proportioning comprises:
2. the Chinese medicine of treatment hepatitis B according to claim 1 is characterized in that: the raw material of this medicine also comprises: Herba Epimedii 10-30 part, Radix Pseudostellariae 5-15 part.
3. the Chinese medicine of treatment hepatitis B according to claim 1 is characterized in that: the raw material of this medicine also comprises: Fructus Ligustri Lucidi 5-20 part, Herba Ecliptae 5-15 part.
4. the Chinese medicine of treatment hepatitis B according to claim 1 is characterized in that: the raw material of this medicine also comprises: Radix Salviae Miltiorrhizae 5-15 part, Endothelium Corneum Gigeriae Galli 5-15 part, Rhizoma Cyperi 10-15 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103246512A CN102349990B (en) | 2011-10-18 | 2011-10-18 | Traditional Chinese medicine for treating hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103246512A CN102349990B (en) | 2011-10-18 | 2011-10-18 | Traditional Chinese medicine for treating hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102349990A true CN102349990A (en) | 2012-02-15 |
| CN102349990B CN102349990B (en) | 2013-05-15 |
Family
ID=45573704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103246512A Expired - Fee Related CN102349990B (en) | 2011-10-18 | 2011-10-18 | Traditional Chinese medicine for treating hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102349990B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104547158A (en) * | 2015-01-30 | 2015-04-29 | 黄瑞兰 | Baicaodan |
| CN104888017A (en) * | 2015-06-18 | 2015-09-09 | 王萧 | Medicine for treating hepatitis B |
| CN105169278A (en) * | 2015-10-12 | 2015-12-23 | 青岛恒波仪器有限公司 | Dandelion oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
| CN105169275A (en) * | 2015-10-12 | 2015-12-23 | 青岛恒波仪器有限公司 | Rheum officinale oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
| CN1820779A (en) * | 2005-02-16 | 2006-08-23 | 苏明 | Medicinal composition for treating hepatitis B and its preparing method |
-
2011
- 2011-10-18 CN CN2011103246512A patent/CN102349990B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
| CN1820779A (en) * | 2005-02-16 | 2006-08-23 | 苏明 | Medicinal composition for treating hepatitis B and its preparing method |
Non-Patent Citations (1)
| Title |
|---|
| 许嘉坤: "中医药抗肝纤维化研究概况", 《实用中医内科杂志》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104547158A (en) * | 2015-01-30 | 2015-04-29 | 黄瑞兰 | Baicaodan |
| CN104888017A (en) * | 2015-06-18 | 2015-09-09 | 王萧 | Medicine for treating hepatitis B |
| CN105169278A (en) * | 2015-10-12 | 2015-12-23 | 青岛恒波仪器有限公司 | Dandelion oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
| CN105169275A (en) * | 2015-10-12 | 2015-12-23 | 青岛恒波仪器有限公司 | Rheum officinale oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102349990B (en) | 2013-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102614440B (en) | Multi-herb antibacterial liquid | |
| CN103007191B (en) | Chinese medicinal composition for treating jaundice | |
| CN103055130B (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof | |
| CN101874867B (en) | Chinese medicinal preparation for treating psoriasis | |
| CN101934025B (en) | Traditional Chinese medicine for clearing away heat and toxic material | |
| CN102327449B (en) | Traditional Chinese medicine for treating gout | |
| CN103028091B (en) | Traditional Chinese medicine composition for treating damp heat of liver and gallbladder | |
| CN103316295B (en) | Traditional Chinese composition for treating rheumatic arthritis | |
| CN101284114A (en) | Medicine for treating rheumatism and rheumatoid disease | |
| CN103211932A (en) | Traditional Chinese medicine composition for treating rheumatism | |
| CN102293967B (en) | Medicine for treating eczema | |
| CN102349990B (en) | Traditional Chinese medicine for treating hepatitis B | |
| CN101653540B (en) | Traditional Chinese medicine composition for treating pustule type psoriasis | |
| CN102188595A (en) | Chinese medicine composition for treating arthritis and preparation method thereof | |
| CN103100035B (en) | Traditional Chinese medicine (TCM) decoction for treating globus hysteriocus | |
| CN1994453B (en) | Oral traditional Chinese medicine for treating qi stagnation and blood stasis type dysmenorrhea | |
| CN101757502A (en) | Medicament for treating traumatic joint periostitis and bursitis | |
| CN105381020A (en) | Topical drug for treating rheumatoid bone pain | |
| CN105770748A (en) | Traditional Chinese medicine composition for treating gouts | |
| CN104825916A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN102716279B (en) | Salvia miltiorrhiza traditional Chinese medicine preparation for treating hypochondriac pain and preparation method thereof | |
| CN102370825B (en) | Traditional Chinese medicine for treating eczema | |
| CN103099997B (en) | Traditional Chinese medicine composition for treating leukoplakia vulvae | |
| CN102327536A (en) | Composite medicinal composition for treating female infertility | |
| CN102406906A (en) | Traditional Chinese medicine composition for treating acute hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130515 Termination date: 20151018 |
|
| EXPY | Termination of patent right or utility model |